Global Demographic Shifts And Emerging Markets Will Create Enduring Opportunity

AN

AnalystConsensusTarget

AnalystConsensusTarget

Not Invested

Based on Analyst Price Targets

Published

02 Mar 25

Updated

04 Oct 25

n/a

n/a

AnalystConsensusTarget's Fair Value

n/a

1Y

-2.4%

7D

-2.7%

Loading

1Y

-2.4%

7D

-2.7%

You can edit this narrative until Oct 5 10:35 AM. Then, changes will post as Updates.

Author's Valuation

UK£3.0424.5% undervalued

AnalystConsensusTarget Fair Value

Shared on 04 Oct 25

Fair value Decreased 0.51%

Analysts have modestly reduced their price target for ConvaTec Group, reflecting a decline from £3.05 to £3.04 per share as they factor in revised sector outlooks and modest adjustments to growth expectations. Analyst Commentary Recent analyst revisions provide a mixed view of ConvaTec Group's prospects, with both optimistic and cautious signals emerging from updated research.

Shared on 01 May 25

Fair value Increased 3.82%

Shared on 23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 17 Apr 25

Fair value Increased 1.73%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 09 Apr 25

Fair value Decreased 7.40%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 02 Apr 25

Fair value Increased 5.44%

Shared on 26 Mar 25

Fair value Decreased 0.34%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 19 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 13 Mar 25

Fair value Decreased 3.03%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

AnalystConsensusTarget Fair Value

UK£3.04

24.5% undervalued

Future estimation in

% p.a.

0

Decrease

Increase

Current revenue growth rate

5.54%

Medical Equipment revenue growth rate

8.58%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

%

0

Decrease

Increase

Current discount rate

8.45%

Calculation

US$370.97m

Earnings '28

x

28.40x

PE Ratio '28

=

US$10.53b

Market Cap '28

US$10.53b

Market Cap '28

/

2.04b

No. shares '28

=

US$5.15

Share Price '28

US$5.15 Share Price '28

Discounted to 2025 @ 7.99% p.a.

=

US$4.09

Fair Value '25

US$4.09 Fair Value '25

Converted to GBP @ 0.7417 USD/GBP Exchange Rate

=

UK£3.03

Fair Value '25